Skip to main content
OpenTrials
Completed

NCT Number: NCT03574467

Functional Outcomes of The Bobath Approach on Patients With Brain Tumors: Comparison With Stroke Patients

The aim of this study is to examine the functional recovery results of the Bobath (NDT) approach in patients with primary brain tumors and compare the results with those of stroke patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Brain Neoplasms Brain Diseases Cardiovascular Diseases Central Nervous System Diseases Central Nervous System Neoplasms Cerebrovascular Disorders Neoplasms Neoplasms by Site Nervous System Diseases Nervous System Neoplasms Stroke Stroke, Acute Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Hacettepe University

Ankara, Altındağ, 06511, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • acute phase patients with brain tumor and stroke in after surgery

Exclusion criteria

  • Modified rankin scale <2
  • High grade tumor
  • Infratentorial tumor
  • GCS<14
  • Rehabilitation session time<3
  • Second or more tumor surgery
  • Second or more stroke
  • Bilateral stroke

Treatment and study plan

Bobath Neurodevelopmental Treatment Approach

Behavioral

The Bobath Neurodevelopmental Treatment (NDT) rehabilitation approach is effective in increasing the functional capacity and acquiring independence in patients with stroke and brain tumor.

Primary outcomes

  1. The Stroke Rehabilitation Assessment of Movement Measure (STREAM)

    Time frame: Patients were evaluated immediately before rehabilitation, and immediately after rehabilitation service, which lasted 4-10 days on average.

    The Stroke Rehabilitation Assessment of Movement Measure (STREAM) is a scale with scores ranging from 0 to 70, which is used to provide an understanding of the levels of movement and quality of hemiplegic patients.

Secondary outcomes

  1. The Functional Independent Measurement (FIM)

    Time frame: Patients were evaluated immediately before rehabilitation, and immediately after rehabilitation service, which lasted 4-10 days on average.

    The Functional Independent Measurement (FIM) is 18-item scale and is scored from 18 (total assistance in all areas) to 126 (complete independence). FIM consists of 13 motor (or physical) and 5 social-cognitive items, assessing self care, sphincter control, transfer, locomotion, communication, social interaction, and cognition. The results from the first 13 items (FIM motor) are summed to develop a motor score with a range of 13 to 91, and these items were used in this study.

  2. Mini-Mental State Examination (MMSE)

    Time frame: Patients were evaluated immediately before rehabilitation, and immediately after rehabilitation service, which lasted 4-10 days on average.

    Mini-Mental State Examination (MMSE) is a scale with scores ranging from 0 to 30, which allows the cognitive levels to be determined by examining the patient's orientation, recording memory, attention and calculation, recall, and language parameters. The score of 0 indicates that the patient has no cognitive functions, and the score of 30 indicates that the patient has a high level of cognitive functions.

Sponsors and collaborators

Lead sponsor

Hacettepe University

Other

Registry information

Official study title

Functional Outcomes of The Bobath Neurodevelopmental Treatment Approach Applied to Patients With Brain Tumors: Comparison With Stroke Patients

Important dates

Study start
2018
Primary completion
2018
Study completion
2018
First posted
Jul 2, 2018
Registry last updated
Jul 2, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.